Rituximab Maintenance Therapy for Marginal Zone B-cell Lymphoma (MZL)

This study is currently recruiting participants.
Verified May 2012 by Dong-A University Hospital
Sponsor:
Information provided by (Responsible Party):
Sung Yong Oh, Dong-A University Hospital
ClinicalTrials.gov Identifier:
NCT01213095
First received: September 30, 2010
Last updated: May 5, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2015
  Estimated Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)